0 XP   0   0   0

ObsEva SA










Financial Health of Obseva




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


ObsEva SA
Buy, Hold or Sell?

Should you buy, hold or sell Obseva?

I guess you are interested in ObsEva SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Obseva

Let's start. I'm going to help you getting a better view of ObsEva SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is ObsEva SA even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how ObsEva SA is doing in the market. If the company is worth buying. The latest step is to find out how other investors value ObsEva SA. The closing price on 2022-12-02 was CHF0.164 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
ObsEva SA Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of ObsEva SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Obseva earns for each CHF1 of revenue.

  • Above 10% is considered healthy but always compare Obseva to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that CHF0.00 for each CHF1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ObsEva SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-100,239.0%+100,239.0%
TTM-100,239.0%YOY-483,495.8%+383,256.9%
TTM-100,239.0%5Y-250,542.0%+150,303.0%
5Y-250,542.0%10Y-185,586.6%-64,955.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM-100,239.0%-281.7%-99,957.3%
YOY-483,495.8%-344.8%-483,151.0%
5Y-250,542.0%-450.1%-250,091.9%
10Y-185,586.6%-541.0%-185,045.6%
1.1.2. Return on Assets

Shows how efficient Obseva is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Obseva to the Biotechnology industry mean.
  • -60.5% Return on Assets means that Obseva generated CHF-0.61 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ObsEva SA:

  • The MRQ is -60.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-60.5%TTM-23.9%-36.7%
TTM-23.9%YOY-24.2%+0.4%
TTM-23.9%5Y-20.1%-3.7%
5Y-20.1%10Y-18.3%-1.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-60.5%-9.9%-50.6%
TTM-23.9%-8.9%-15.0%
YOY-24.2%-9.3%-14.9%
5Y-20.1%-11.7%-8.4%
10Y-18.3%-12.7%-5.6%
1.1.3. Return on Equity

Shows how efficient Obseva is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Obseva to the Biotechnology industry mean.
  • 0.0% Return on Equity means Obseva generated CHF0.00 for each CHF1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ObsEva SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-25.6%+25.6%
TTM-25.6%YOY-104.6%+79.0%
TTM-25.6%5Y-44.2%+18.6%
5Y-44.2%10Y-36.7%-7.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.0%+12.0%
TTM-25.6%-11.5%-14.1%
YOY-104.6%-10.8%-93.8%
5Y-44.2%-14.2%-30.0%
10Y-36.7%-15.2%-21.5%

1.2. Operating Efficiency of ObsEva SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Obseva is operating .

  • Measures how much profit Obseva makes for each CHF1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Obseva to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated CHF0.00  for each CHF1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ObsEva SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-90,387.9%+90,387.9%
TTM-90,387.9%YOY-464,606.3%+374,218.3%
TTM-90,387.9%5Y-245,737.8%+155,349.9%
5Y-245,737.8%10Y-182,028.0%-63,709.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM-90,387.9%-271.0%-90,116.9%
YOY-464,606.3%-325.9%-464,280.4%
5Y-245,737.8%-454.0%-245,283.8%
10Y-182,028.0%-537.1%-181,490.9%
1.2.2. Operating Ratio

Measures how efficient Obseva is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are CHF0.00 for each CHF1 in net sales.

Let's take a look of the Operating Ratio trends of ObsEva SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM898.781-898.781
TTM898.781YOY4,672.271-3,773.490
TTM898.7815Y2,461.600-1,562.819
5Y2,461.60010Y1,823.408+638.193
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM898.7813.504+895.277
YOY4,672.2713.604+4,668.667
5Y2,461.6005.132+2,456.468
10Y1,823.4086.371+1,817.037

1.3. Liquidity of ObsEva SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Obseva is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.98 means the company has CHF2.98 in assets for each CHF1 in short-term debts.

Let's take a look of the Current Ratio trends of ObsEva SA:

  • The MRQ is 2.980. The company is able to pay all its short-term debts. +1
  • The TTM is 3.154. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.980TTM3.154-0.173
TTM3.154YOY2.924+0.229
TTM3.1545Y5.563-2.409
5Y5.56310Y5.876-0.313
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9805.117-2.137
TTM3.1545.755-2.601
YOY2.9245.854-2.930
5Y5.5636.511-0.948
10Y5.8766.222-0.346
1.3.2. Quick Ratio

Measures if Obseva is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Obseva to the Biotechnology industry mean.
  • A Quick Ratio of 0.88 means the company can pay off CHF0.88 for each CHF1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ObsEva SA:

  • The MRQ is 0.876. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.426. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.876TTM2.426-1.550
TTM2.426YOY2.639-0.213
TTM2.4265Y5.233-2.807
5Y5.23310Y5.600-0.367
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8764.284-3.408
TTM2.4264.664-2.238
YOY2.6394.787-2.148
5Y5.2335.218+0.015
10Y5.6005.182+0.418

1.4. Solvency of ObsEva SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Obseva assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Obseva to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.04 means that Obseva assets are financed with 103.9% credit (debt) and the remaining percentage (100% - 103.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ObsEva SA:

  • The MRQ is 1.039. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.727. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ1.039TTM0.727+0.311
TTM0.727YOY0.671+0.056
TTM0.7275Y0.447+0.280
5Y0.44710Y0.362+0.085
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0390.278+0.761
TTM0.7270.277+0.450
YOY0.6710.306+0.365
5Y0.4470.367+0.080
10Y0.3620.403-0.041
1.4.2. Debt to Equity Ratio

Measures if Obseva is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Obseva to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has CHF0.00 debt for each CHF1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ObsEva SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.288-1.288
TTM1.288YOY2.999-1.712
TTM1.2885Y1.212+0.075
5Y1.21210Y0.934+0.278
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.315-0.315
TTM1.2880.317+0.971
YOY2.9990.319+2.680
5Y1.2120.403+0.809
10Y0.9340.462+0.472

2. Market Valuation of ObsEva SA

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every CHF1 in earnings Obseva generates.

  • Above 15 is considered overpriced but always compare Obseva to the Biotechnology industry mean.
  • A PE ratio of -3.92 means the investor is paying CHF-3.92 for every CHF1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ObsEva SA:

  • The EOD is -0.423. Company is losing money. -2
  • The MRQ is -3.916. Company is losing money. -2
  • The TTM is 70.416. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD-0.423MRQ-3.916+3.494
MRQ-3.916TTM70.416-74.332
TTM70.416YOY-10.545+80.961
TTM70.4165Y-1.634+72.050
5Y-1.63410Y-1.210-0.424
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.423-8.986+8.563
MRQ-3.916-9.792+5.876
TTM70.416-16.243+86.659
YOY-10.545-20.876+10.331
5Y-1.634-16.665+15.031
10Y-1.210-14.732+13.522
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Obseva.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of ObsEva SA:

  • The MRQ is 6.117. Seems overpriced? -1
  • The TTM is 2.953. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ6.117TTM2.953+3.164
TTM2.953YOY-25.792+28.745
TTM2.9535Y277.567-274.615
5Y277.56710Y277.5670.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.117-0.032+6.149
TTM2.9530.004+2.949
YOY-25.7920.016-25.808
5Y277.5670.006+277.561
10Y277.5670.003+277.564

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Obseva is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -61.07 means the investor is paying CHF-61.07 for each CHF1 in book value.

Let's take a look of the Price to Book Ratio trends of ObsEva SA:

  • The EOD is -6.590. Bad. Book ratio is negative. -2
  • The MRQ is -61.074. Bad. Book ratio is negative. -2
  • The TTM is -11.604. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-6.590MRQ-61.074+54.485
MRQ-61.074TTM-11.604-49.470
TTM-11.604YOY9.775-21.379
TTM-11.6045Y3.347-14.950
5Y3.34710Y2.479+0.868
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.5901.835-8.425
MRQ-61.0742.006-63.080
TTM-11.6042.774-14.378
YOY9.7753.453+6.322
5Y3.3472.713+0.634
10Y2.4792.402+0.077
2. Total Gains per Share

2.4. Latest News of ObsEva SA

Does ObsEva SA still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from ObsEva SA to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-12-01
23:15
ObsEva SA (OBSV) Reports Q3 Loss, Lags Revenue EstimatesRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ObsEva SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.356-0.129-64%0.053-770%-0.058-84%-0.001-100%
Book Value Growth---15.195-3.973-74%-0.356-98%-1.012-93%-0.800-95%
Book Value Per Share---0.0250.303-108%0.360-107%0.841-103%0.836-103%
Book Value Per Share Growth---14.298-3.691-74%-0.270-98%-0.891-94%-0.691-95%
Current Ratio--2.9803.154-5%2.924+2%5.563-46%5.876-49%
Debt To Asset Ratio--1.0390.727+43%0.671+55%0.447+132%0.362+187%
Debt To Equity Ratio---1.288-100%2.999-100%1.212-100%0.934-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.388-0.189-51%-0.243-37%-0.240-38%-0.208-46%
Eps Growth---0.6405.848-111%0.008-8154%1.474-143%1.474-143%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----1002.3900%-4834.9580%-2505.4200%-1855.8660%
Operating Margin----903.8790%-4646.0630%-2457.3780%-1820.2800%
Operating Ratio---898.781-100%4672.271-100%2461.600-100%1823.408-100%
Pb Ratio-6.590+89%-61.074-11.604-81%9.775-725%3.347-1925%2.479-2564%
Pe Ratio-0.423+89%-3.91670.416-106%-10.545+169%-1.634-58%-1.210-69%
Peg Ratio--6.1172.953+107%-25.792+522%277.567-98%277.567-98%
Price Per Share0.164-827%1.5201.925-21%2.530-40%4.520-66%3.348-55%
Price To Total Gains Ratio-0.461+89%-4.27213.319-132%-41.639+875%-29.123+582%-29.123+582%
Profit Growth---61.590627.666-110%7.599-911%131.809-147%99.924-162%
Quick Ratio--0.8762.426-64%2.639-67%5.233-83%5.600-84%
Return On Assets---0.605-0.239-61%-0.242-60%-0.201-67%-0.183-70%
Return On Equity----0.2560%-1.0460%-0.4420%-0.3670%
Total Gains Per Share---0.356-0.129-64%0.053-770%-0.058-84%-0.001-100%
Total Gains Per Share Growth---0.8550.929-192%0.717-219%-0.045-95%-0.264-69%
Usd Book Value---2244952.50027319993.750-108%32460273.125-107%75868506.000-103%75413260.741-103%
Usd Book Value Change Per Share---0.380-0.138-64%0.057-770%-0.062-84%-0.001-100%
Usd Book Value Per Share---0.0270.323-108%0.384-107%0.898-103%0.892-103%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.414-0.202-51%-0.259-37%-0.256-38%-0.222-46%
Usd Price Per Share0.175-827%1.6232.055-21%2.701-40%4.825-66%3.574-55%
Usd Profit---35011865.000-17034097.500-51%-21905900.625-37%-21644203.000-38%-18784955.648-46%
Usd Revenue---5364988.125-100%5070.625-100%1075079.250-100%796355.000-100%
Usd Total Gains Per Share---0.380-0.138-64%0.057-770%-0.062-84%-0.001-100%
 EOD+2 -3MRQTTM+5 -23YOY+6 -225Y+7 -2110Y+7 -21

3.2. Fundamental Score

Let's check the fundamental score of ObsEva SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.423
Price to Book Ratio (EOD)Between0-1-6.590
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.876
Current Ratio (MRQ)Greater than12.980
Debt to Asset Ratio (MRQ)Less than11.039
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.605
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of ObsEva SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.945
Ma 20Greater thanMa 500.168
Ma 50Greater thanMa 1000.172
Ma 100Greater thanMa 2000.304
OpenGreater thanClose0.187
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Total Stockholder Equity 41,6242,54544,169-11,83032,339-4,37427,965-30,068-2,103
Net Debt  -32,143-4,037-36,1808,105-28,0754,399-23,67643,02219,346
Net Tangible Assets  15,0164,65019,666-11,8307,836-3,7744,062-10,668-6,606



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in CHF. All numbers in thousands.

Summary
Total Assets54,184
Total Liabilities56,287
Total Stockholder Equity-2,103
 As reported
Total Liabilities 56,287
Total Stockholder Equity+ -2,103
Total Assets = 54,184

Assets

Total Assets54,184
Total Current Assets48,677
Long-term Assets48,677
Total Current Assets
Cash And Cash Equivalents 14,126
Net Receivables 180
Other Current Assets 34,371
Total Current Assets  (as reported)48,677
Total Current Assets  (calculated)48,677
+/-0
Long-term Assets
Property Plant Equipment 470
Intangible Assets 4,503
Other Assets 534
Long-term Assets  (as reported)5,507
Long-term Assets  (calculated)5,507
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities16,333
Long-term Liabilities39,954
Total Stockholder Equity-2,103
Total Current Liabilities
Short-term Debt 549
Other Current Liabilities 15,784
Total Current Liabilities  (as reported)16,333
Total Current Liabilities  (calculated)16,333
+/-0
Long-term Liabilities
Long term Debt 32,923
Other Liabilities 7,031
Long-term Liabilities Other 563
Long-term Liabilities  (as reported)39,954
Long-term Liabilities  (calculated)40,517
+/- 563
Total Stockholder Equity
Common Stock6,875
Retained Earnings -481,575
Accumulated Other Comprehensive Income 35,060
Other Stockholders Equity 437,537
Total Stockholder Equity (as reported)-2,103
Total Stockholder Equity (calculated)-2,103
+/-0
Other
Capital Stock6,875
Cash and Short Term Investments 14,126
Common Stock Shares Outstanding 83,885
Liabilities and Stockholders Equity 54,184
Net Debt 19,346
Net Invested Capital 30,820
Net Tangible Assets -6,606
Net Working Capital 32,344
Short Long Term Debt Total 33,472



Balance Sheet

Currency in CHF. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
> Total Assets 
71,590
0
0
57,416
45,525
123,090
106,146
92,857
135,235
120,122
191,648
180,977
167,440
148,535
128,539
127,098
103,943
97,381
79,198
84,936
65,447
101,261
95,182
97,636
88,991
89,144
54,184
54,18489,14488,99197,63695,182101,26165,44784,93679,19897,381103,943127,098128,539148,535167,440180,977191,648120,122135,23592,857106,146123,09045,52557,4160071,590
   > Total Current Assets 
54,518
0
0
39,766
28,706
106,193
84,228
70,720
113,114
98,012
169,547
158,804
145,240
123,852
104,024
97,757
74,773
68,391
50,384
56,296
36,968
72,969
67,391
72,058
63,517
64,262
48,677
48,67764,26263,51772,05867,39172,96936,96856,29650,38468,39174,77397,757104,024123,852145,240158,804169,54798,012113,11470,72084,228106,19328,70639,7660054,518
       Cash And Cash Equivalents 
54,275
0
0
38,910
25,508
104,158
82,077
68,358
110,841
95,435
166,835
156,439
138,640
117,321
98,492
91,017
69,370
62,042
44,965
50,597
31,183
67,998
58,923
62,884
54,734
57,553
14,126
14,12657,55354,73462,88458,92367,99831,18350,59744,96562,04269,37091,01798,492117,321138,640156,439166,83595,435110,84168,35882,077104,15825,50838,9100054,275
       Net Receivables 
69
0
0
229
783
988
676
683
783
791
630
695
885
993
1,247
776
1,044
514
314
516
397
364
458
3,428
3,560
953
180
1809533,5603,4284583643975163145141,0447761,2479938856956307917836836769887832290069
       Other Current Assets 
174
0
0
627
2,415
1,047
1,475
1,679
1,490
1,786
2,082
1,670
5,715
5,538
4,285
5,964
4,359
5,835
5,105
5,183
5,388
4,607
8,010
5,746
5,223
5,756
34,371
34,3715,7565,2235,7468,0104,6075,3885,1835,1055,8354,3595,9644,2855,5385,7151,6702,0821,7861,4901,6791,4751,0472,41562700174
   > Long-term Assets 
17,072
0
0
17,650
16,819
16,897
21,918
22,137
22,121
22,110
22,101
22,173
22,200
24,683
24,515
29,341
29,170
28,990
28,814
28,640
28,479
28,292
27,791
25,578
25,474
24,882
5,507
5,50724,88225,47425,57827,79128,29228,47928,64028,81428,99029,17029,34124,51524,68322,20022,17322,10122,11022,12122,13721,91816,89716,81917,6500017,072
       Property Plant Equipment 
124
0
0
131
121
118
118
339
323
310
305
292
319
2,802
2,634
2,463
2,287
2,106
1,928
1,747
1,576
1,404
899
792
683
584
470
4705846837928991,4041,5761,7471,9282,1062,2872,4632,6342,80231929230531032333911811812113100124
       Intangible Assets 
16,857
0
0
17,425
16,608
16,608
21,608
21,608
21,608
21,608
21,608
21,608
21,608
21,608
21,608
26,608
26,608
26,608
26,608
26,608
26,608
26,608
26,608
24,503
24,503
23,903
4,503
4,50323,90324,50324,50326,60826,60826,60826,60826,60826,60826,60826,60821,60821,60821,60821,60821,60821,60821,60821,60821,60816,60816,60817,4250016,857
       Long-term Assets Other 
91
0
0
94
90
171
192
190
190
192
188
273
273
273
273
270
275
276
278
285
295
280
284
283
288
395
534
53439528828328428029528527827627527027327327327318819219019019217190940091
> Total Liabilities 
6,915
0
0
9,301
9,484
11,607
9,826
11,290
12,584
14,862
15,000
16,144
20,524
23,874
34,235
57,271
54,988
59,260
55,518
62,750
57,093
51,794
53,558
53,467
56,652
61,179
56,287
56,28761,17956,65253,46753,55851,79457,09362,75055,51859,26054,98857,27134,23523,87420,52416,14415,00014,86212,58411,2909,82611,6079,4849,301006,915
   > Total Current Liabilities 
4,252
0
0
6,598
6,652
8,748
6,973
8,450
9,430
11,746
11,914
13,091
16,929
18,393
28,335
26,754
19,468
23,791
19,985
27,267
21,704
17,004
18,521
18,768
23,507
20,779
16,333
16,33320,77923,50718,76818,52117,00421,70427,26719,98523,79119,46826,75428,33518,39316,92913,09111,91411,7469,4308,4506,9738,7486,6526,598004,252
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
580
0
0
0
0
0
0
0
0
0
698
686
624
549
5496246866980000000005800000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
580
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000005800000000000000
       Accounts payable 
595
0
0
883
2,383
1,836
1,791
2,662
2,865
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000002,8652,6621,7911,8362,38388300595
       Other Current Liabilities 
3,657
0
0
5,715
4,269
6,912
5,182
5,788
6,565
11,746
11,914
13,091
16,929
18,393
28,335
26,754
19,468
23,791
19,985
27,267
21,704
17,004
18,521
18,070
22,821
20,155
15,784
15,78420,15522,82118,07018,52117,00421,70427,26719,98523,79119,46826,75428,33518,39316,92913,09111,91411,7466,5655,7885,1826,9124,2695,715003,657
   > Long-term Liabilities 
2,663
0
0
2,703
2,832
2,859
2,853
2,840
3,154
3,116
3,086
3,053
3,595
5,481
5,900
30,517
35,520
35,469
35,533
35,483
35,389
34,790
35,037
34,699
33,145
40,400
39,954
39,95440,40033,14534,69935,03734,79035,38935,48335,53335,46935,52030,5175,9005,4813,5953,0533,0863,1163,1542,8402,8532,8592,8322,703002,663
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,295
26,252
26,142
26,086
26,006
25,973
0
0
0025,97326,00626,08626,14226,25226,2950000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
3,154
3,116
3,086
3,053
3,595
3,514
4,059
4,022
9,062
9,074
9,192
9,188
9,137
8,648
8,951
8,693
7,172
7,147
7,031
7,0317,1477,1728,6938,9518,6489,1379,1889,1929,0749,0624,0224,0593,5143,5953,0533,0863,1163,15400000000
> Total Stockholder Equity
64,675
0
0
48,115
36,041
111,483
96,320
81,567
122,651
105,260
176,648
164,833
146,916
124,661
94,304
69,827
48,955
38,121
23,680
22,186
8,354
49,467
41,624
44,169
32,339
27,965
-2,103
-2,10327,96532,33944,16941,62449,4678,35422,18623,68038,12148,95569,82794,304124,661146,916164,833176,648105,260122,65181,56796,320111,48336,04148,1150064,675
   Common Stock
1,694
0
0
1,735
1,740
2,240
2,244
2,265
2,864
2,871
3,375
3,413
3,420
3,427
3,442
3,448
3,499
3,699
3,781
4,370
4,574
6,948
6,948
6,948
6,489
6,812
6,875
6,8756,8126,4896,9486,9486,9484,5744,3703,7813,6993,4993,4483,4423,4273,4203,4133,3752,8712,8642,2652,2442,2401,7401,735001,694
   Retained Earnings -481,575-448,777-436,975-417,724-418,543-399,399-379,395-361,826-337,442-319,274-297,411-271,969-244,362-209,606-183,927-163,249-144,659-126,473-106,667-89,455-72,461-55,137-39,599-27,85900-39,437
   Accumulated Other Comprehensive Income 
-58
0
0
0
-102
0
0
0
-172
0
0
0
-281
0
0
0
-1,024
0
0
0
-1,734
0
0
31,014
32,195
33,236
35,060
35,06033,23632,19531,01400-1,734000-1,024000-281000-172000-102000-58
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
353,651
356,822
414,483
424,567
424,561
430,630
0
0
00430,630424,561424,567414,483356,822353,6510000000000000000000
   Treasury Stock000-630-630-938000000000000000000000
   Other Stockholders Equity 
102,476
0
0
74,239
74,002
164,380
166,537
168,757
226,626
228,862
317,932
324,669
327,704
330,840
335,224
338,348
343,891
353,696
357,341
379,642
384,909
441,918
453,219
423,931
430,630
436,694
437,537
437,537436,694430,630423,931453,219441,918384,909379,642357,341353,696343,891338,348335,224330,840327,704324,669317,932228,862226,626168,757166,537164,38074,00274,23900102,476



Balance Sheet

Currency in CHF. All numbers in thousands.




Cash Flow

Currency in CHF. All numbers in thousands.




Income Statement

Currency in CHF. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue20,113
Cost of Revenue--
Gross Profit-20,113
 
Operating Income (+$)
Gross Profit-
Operating Expense-54,514
Operating Income-54,514-54,514
 
Operating Expense (+$)
Research Development53,136
Selling General Administrative21,491
Selling And Marketing Expenses-
Operating Expense54,51474,627
 
Net Interest Income (+$)
Interest Income600
Interest Expense-4,251
Net Interest Income-3,651-3,651
 
Pretax Income (+$)
Operating Income-54,514
Net Interest Income-3,651
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-58,165-50,863
EBIT - interestExpense = -58,165
-58,165
-54,126
Interest Expense4,251
Earnings Before Interest and Taxes (ebit)-53,914-53,914
Earnings Before Interest and Taxes (ebitda)-53,178
 
After tax Income (+$)
Income Before Tax-58,165
Tax Provision-212
Net Income From Continuing Ops-58,377-58,377
Net Income-58,377
Net Income Applicable To Common Shares-58,377
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses54,514
Total Other Income/Expenses Net-3,6513,651
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ZCL.CC
9 hours ago

I found you a Golden Cross on the daily chart of ZCL.CC.

ZCL.CC Daily Candlestick Chart
XPC.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XPC.CC.

XPC.CC Daily Candlestick Chart
XNC.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XNC.CC.

XNC.CC Daily Candlestick Chart
XMY.CC
9 hours ago

I found you a Three White Soldiers Candle Pattern on the daily chart of XMY.CC.

XMY.CC Daily Candlestick Chart
XFT.CC
9 hours ago

I found you a Rising Three Methods Candle Pattern on the daily chart of XFT.CC.

XFT.CC Daily Candlestick Chart
WING.CC
9 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of WING.CC.

WING.CC Daily Candlestick Chart
vUSDC.CC
9 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of vUSDC.CC.

vUSDC.CC Daily Candlestick Chart
VOLLAR.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
UUU.CC
9 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of UUU.CC.

UUU.CC Daily Candlestick Chart
UGAS.CC
9 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of UGAS.CC.

UGAS.CC Daily Candlestick Chart
UBQ.CC
9 hours ago

I found you a Death Cross on the daily chart of UBQ.CC.

UBQ.CC Daily Candlestick Chart
TRXBULL.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRXBULL.CC.

TRXBULL.CC Daily Candlestick Chart
TH.CC
9 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TH.CC.

TH.CC Daily Candlestick Chart
THC.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TEL.CC
9 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TEL.CC.

TEL.CC Daily Candlestick Chart
SWG.CC
9 hours ago

I found you a Death Cross on the daily chart of SWG.CC.

SWG.CC Daily Candlestick Chart
SNC.CC
9 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SHROOM.CC
9 hours ago

I found you a Morning Star Candle Pattern on the daily chart of SHROOM.CC.

SHROOM.CC Daily Candlestick Chart
SATT.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SATT.CC.

SATT.CC Daily Candlestick Chart
RYO.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RYO.CC.

RYO.CC Daily Candlestick Chart
REAP.CC
10 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of REAP.CC.

REAP.CC Daily Candlestick Chart
RBN.CC
10 hours ago

I found you a Death Cross on the daily chart of RBN.CC.

RBN.CC Daily Candlestick Chart
RAK.CC
10 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RAK.CC.

RAK.CC Daily Candlestick Chart
PLAY.CC
10 hours ago

I found you a Death Cross on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart